Last reviewed · How we verify
NCT05837637
The Vietnamese Smell Identification Test in the Diagnosis of Parkinson's Disease
trial testing The Vietnamese Smell Identification test (VSIT), the Brief Smell Identification test (BSIT) in Hyposmia in 218 participants. Status unknown.
1 December 2024
Quick facts
| Lead sponsor | University Medical Center Ho Chi Minh City (UMC) |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 218 |
| Start date | 5 May 2023 |
| Primary completion | 1 December 2024 |
| Estimated completion | 1 September 2025 |
| Sites | 1 location across Vietnam |
Drugs / interventions tested
- The Vietnamese Smell Identification test (VSIT), the Brief Smell Identification test (BSIT)
Conditions studied
- Hyposmia — all drugs for Hyposmia →
- Parkinson Disease — all drugs for Parkinson Disease →
Sponsor
University Medical Center Ho Chi Minh City (UMC)
Who can join
18 and older, any sex, with Hyposmia or Parkinson Disease. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The goal of this observational study is to assess the value of the Vietnamese smell identification test (VSIT) in the diagnosis of Parkinson's disease, and compare it with the commonly used test in the world, Brisk smell identification test (BSIT) The main questions it aims to answer are: * The sensitivity, specificity, positive predictive value, and negative predictive value of the VSIT in the diagnosis of Parkinson's disease? * The sensitivity, specificity, positive predictive value, and negative predictive value of the BSIT in the diagnosis of Parkinson's disease? * Factors that associated with olfactory identification ability in PD patients? Process: * Participants will be assessed cognitive station using MMSE * Information on socio-demographic including age, gender, education, occupation, place of residence of both groups, and disease-related characteristics will be collected. * Participants with Parkinson disease will be then assessed with the following instruments: Movement Disorder Society Unified Parkinson's Disease Rating Scale (MDS-UPDRS), Hoehn \& Yarh scale, and Beck Depression Inventory * The case and control groups will be assessed by the Vietnamese Smell Identification Test and Brisk Smell Identification Test
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Comparing smell identification ability among different motor subtypes of Parkinson's disease using the Vietnamese Smell Identification Test and the Brief Smell Identification Test.
Huyen Thi Dang T, Truong D, Vinh Nguyen K, Le Ngoc Ha U, et al · · 2024 · PMID 39318472 · DOI 10.1016/j.prdoa.2024.100270
Verify or expand the search:
- PubMed search for NCT05837637
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Hyposmia
Currently open trials in the same condition.
- NCT06733636 — Scents of Progress: Leveraging a Novel Device for Olfactory Training in Older Adults · NA · recruiting
- NCT06817499 — Treatment of Olfactory Dysfunction Using Vagus Nerve Stimulation · NA · active not recruiting
- NCT05364125 — Olfactory Training on Smell Dysfunction Patients in HK · NA · recruiting
Other University Medical Center Ho Chi Minh City (UMC) trials
Trials by the same sponsor.
- NCT06768463 — Cytoreductive Gastrectomy After Systemic Therapy Versus Systemic Therapy Alone For Limited Metastasis Gastric Cancer · NA · recruiting
- NCT06595290 — Vietnamese Rapid Acceleration Protocol for Intensifying Drug Therapy in Heart Failure With Reduced Ejection Fraction · NA · recruiting
- NCT07000383 — Evaluation of the Efficacy and Safety of Gelsectan in the Treatment of Diarrhea-predominant Irritable Bowel Syndrome · NA · recruiting
- NCT07100769 — Application of Real-time Ultrasound Guidance in Thoracic Epidural Catheter Placement · NA · recruiting
- NCT06648720 — Efficacy and Safety of Shortening Dual Antiplatelet Therapy Duration with IVUS Guidance in PCI Patients · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05837637 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University Medical Center Ho Chi Minh City (UMC)
- Last refreshed: 14 November 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05837637.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing